Kidney Week

Clinical Practice Session

Vanguard Medicine: Novel Therapies on the Horizon

October 22, 2020 | 02:30 PM - 04:30 PM

Location: Simulive

Session Description

There are several novel therapies in the pipeline and new indications for approved drugs in the management of glomerular disease, lupus, and obesity. This session reviews mechanisms, risks, and benefits of therapies for several disease processes in CKD.

Learning Objective(s)

• Discuss real-world use and safety signals for novel therapeutics
• Outline emerging indications for approved therapies

Learning Pathway(s)

• Chronic Kidney Disease
• Acute Kidney Injury

Moderators

• Derek M. Fine, MD
• Melanie P. Hoenig, DrMed, MD

Presentations

• New Options for Weight Loss in CKD: Bardoxolone and GLP-1 Agonists
  02:30 PM - 03:00 PM
  Glenn Matthew Chertow, MD, MPH, FASN
  

  Glenn Matthew Chertow, MD, MPH, FASN

New Options for Weight Loss in CKD: Bardoxolone and GLP-1 Agonists

October 22, 2020 | 02:30 PM - 03:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Sparsentan: An Endothelin Receptor Antagonist/Angiotensin Receptor Blocker for FSGS
  03:00 PM - 03:30 PM
  Kirk N. Campbell, MD, FASN
  

  Kirk N. Campbell, MD, FASN

Sparsentan: An Endothelin Receptor Antagonist/Angiotensin Receptor Blocker for FSGS

October 22, 2020 | 03:00 PM - 03:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Emerging Therapies in Lupus and FSGS
  03:30 PM - 04:00 PM
  Patrick H. Nachman, MD, FASN 
  
  

  Patrick H. Nachman, MD, FASN

Emerging Therapies in Lupus and FSGS

October 22, 2020 | 03:30 PM - 04:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• New Formulations of Gadolinium: Still Contraindicated in Advanced CKD?
  04:00 PM - 04:30 PM
  Kirsten L. Johansen, MD, FASN 
  
  

  Kirsten L. Johansen, MD, FASN

  Dr. Johansen is Chief of Nephrology at Hennepin Healthcare and Professor of Medicine at the University of Minnesota. She is the Director of the United States Renal Data System and co-Director of the Chronic Disease Research Group at Hennepin Healthcare Research Institute.

New Formulations of Gadolinium: Still Contraindicated in Advanced CKD?

October 22, 2020 | 04:00 PM - 04:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.